Pooled Analysis of Pralatrexate Single-Agent Studies in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma

In conclusion, these pooled analysis results further support using pralatrexate in patients with r/r PTCL. Prospective studies are needed to confirm the findings of subgroups analyses.PMID:38429077 | DOI:10.1182/bloodadvances.2023010441

Source: Adv Data - March 1, 2024 Category: Epidemiology Authors: Owen A O'Connor Bor-Sheng Ko Ming-Chung Wang Dai Maruyama Yuqin Song Ee Min Yeoh Nick Manamley Kensei Tobinai Source Type: research